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ABSTRACT
The limited number of progenitor stem cells in umbilical cord blood (UCB) enforces the optimization and
strict control of all the procedures involved in its therapeutic use—ie, collection, processing, cryopreservation,
thawing, and transportation—to ensure graft potency at transplantation. For this reason, international UCB
standards recommend storage of a cell sample attached to the UCB unit as a quantitative and functional control
of the unit selected for transplantation. To validate the use of the sample attached to the UCB unit as a
quality-control tool for the final product, UCB units (n  20) stored in liquid nitrogen with the Bioarchive
system were analyzed. The UCB units and their attached segments were thawed, and the number and viability
of total nucleated cells, mononucleated cells, CD45 cells, and CD34 cells were determined, as were
colony-forming cell counts. There was no significant difference between UCB units and segments for any of
the parameters assessed. Additionally, the linear correlation coefficient (R2) in these paired samples was 0.85
and 0.78 for CD34 cells and colony-forming cells, respectively. In conclusion, the cell sample in the tube
segment physically linked to the transplant UCB bag predicts the total cell content and functionality of the unit
and may serve as a source for final quality control of the UCB unit before transplantation.
© 2005 American Society for Blood and Marrow Transplantation
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sNTRODUCTION
Assessment of graft quality is one of the most
elevant issues in hematopoietic stem cell transplanta-
ion [1,2], particularly in the case of a cord blood bank,
here the stored units may be used years after their
ryopreservation. Therefore, a reliable method to as-
ess the cell content and viability of a graft before
ransplantation is crucial. Although it has been shown
hat the number of total nucleated cells (TNCs),
D34 cells, and colony-forming cells (CFCs) per
ilogram body weight of the recipient in the graft are
ood predictors of patient survival [3], all of these
ariables are normally deﬁned before cryopreserva-
ion. However, the quality of a cord blood graft might
e affected during the freezing process, storage, and
ransportation to the transplant unit, as well as during
he thawing process.
The importance of CFC content for all sources of
rogenitors in the hematologic recovery after trans-
B & M Tlantation has been established by several authors
4-6]. Recently, McKenna et al. [7] reported that poor
lonogenicity obtained after thawing resulted in en-
raftment failure of an umbilical cord blood (UCB)
nit that had been characterized exclusively by the
refreeze tests. These studies point to the relevance of
postfreezing functional analysis of the graft to dem-
nstrate its adequacy as a ﬁnal quality control (QC)
est before transplantation.
The use of a tube segment attached to the UCB
nit containing an identical aliquot of the cryopre-
erved product that is exposed to the same postpro-
essing freezing and storage conditions as the unit has
een proposed as a QC tool for UCB banking [7,8].
ell counts, CD34 analysis, and CFC assessment are
ecommended by UCB standards for the qualiﬁcation
f the graft, and all of them can be performed from the
egment attached to the UCB unit.The aim of this study was to investigate the use of
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2he segment attached to the UCB unit for qualiﬁca-
ion of the unit for transplantation. A paired study was
erformed that compared cell quantity and viability,
ncluding CFCs, in the attached segment with that in
he UCB unit. Our results show that the segment may
erve as a predictor of the unit’s cellular content and
iability after thawing.
ATERIAL AND METHODS
ord Blood Collection
Placental UCB was collected at several maternity
linics within the Barcelona Cord Blood Bank pro-
ram. Informed consent was obtained according to
outine procedure. The cord blood, collected with the
lacenta in utero, was drained by gravity from the
mbilical vein in a collection bag (MacoPharma,
ourcoing, France) containing 29 mL of citrate phos-
hate dextrose. The collected blood was stored at 4°C
ntil processing and was cryopreserved within
8 hours after collection.
rocessing and Cryopreservation
The UCB units were volume-reduced by follow-
ng a modiﬁed approach of the automated procedure
escribed previously [9]. This consisted of a double
uffy coat collection after hydroxyethyl starch addi-
ion (Grifols, Barcelona, Spain) by using the Sepax
-100 device and the UCB/hydroxyethyl starch pro-
ocol (Biosafe, Eysins, Switzerland). After dimethyl
ulfoxide addition (10% ﬁnal concentration), the con-
entrated cells were transferred to a freezing bag
Sepax cell-separation kit CS-530; Biosafe) that was
ompatible with the Bioarchive system (Thermogen-
sis, Rancho Cordova, CA). The tube attached to the
reezing bag was ﬁlled with cell concentrate by
queezing the freezing bag. Three segments were
ealed in the attached tube that contained approxi-
ately 200 L each. The tube was left attached to the
ag. The UCB unit (bag and segments) was then
verwrapped with a Bioarchive overwrap bag (Ther-
ogenesis, Rancho Cordova, CA).
Cryopreservation was performed by using a pro-
rammed freezing rate in the Bioarchive at a starting
emperature of 10°C, with a cooling rate of 10°C/min
ntil 3°C (maximum rate to 13°C and 2°C/min
ntil 50°C; mean cooling rate of 3°C/min), and
tored in the liquid nitrogen phase of the same device.
Twenty UCB units were used in this study. These
nits had been rejected after conventional processing
rom the Barcelona Cord Blood Bank inventory be-
ause of lack of documentation (n  3), positive ste-
ility test (n  7), and/or low content of CD34 cells
n  10). The mean content of CD34 cells was
.20%  0.1% before cryopreservation, whereas the
edian content in our entire inventory is 0.31%. The f
48torage time for the units used was more than 5 years
or 6 units, 5 years for 8 units, and between 3 and 5
ears for the remaining 6 units.
hawing
UCB units were removed from the Bioarchive and
mmersed in liquid nitrogen to separate the attached
egment for further analysis. At the time of analysis,
CB bags or the attached segments were thawed by
mmersion in a 37°C water bath, mixed thoroughly,
nd analyzed without delay, according to the different
C assay described below.
uality Controls
Automatic cell count. The TNC count was per-
ormed for each sample by using an automatic cell
ounter that detects and measures changes in electri-
al resistance (impedance) when a particle in a con-
uctive liquid passes through the device (ACTdiff;
oulter, Miami, FL).
Flow cytometry. The method used was the lysis and
onwash single-platform CD34 measurement de-
cribed previously [10]. Brieﬂy, samples drawn just
fter thawing were incubated for 20 minutes at 4°C in
he dark with anti-human phycoerythrin-labeled
onoclonal antibody against CD34 and ﬂuorescein
sothiocyanate–labeled CD45 at saturating concentra-
ion (Becton Dickinson, Franklin Lakes, NJ). After
ncubation, samples were lysed in ammonium chloride
ﬁnal dilution of the sample, 1:10) for 5 minutes at 4°C
n the presence of 1 g of 7-aminoactinomycin D for
ell viability assessment. Twenty microliters of com-
ercially available ﬂuorescent microbeads were added
nd gently mixed for an internal standard before ac-
uisition according to the manufacturer’s instructions
Perfect-Count; Cytognos, Salamanca, Spain) [11] to
valuate the absolute count. The cell subsets were
hen analyzed by their ﬂuorescence proﬁle and for-
ard scatter (FSC)/side scatter (SSC) characteristics
n a FACSCalibur cytometer (Becton Dickinson) by
sing CellQuest software (Becton Dickinson) and the
nternational Society of Hematotherapy and Graft
ngineering recommendations for gating [10].
D45 cells, mononucleated cells (MNCs), CD34
ells, and 7-aminoactinomicin D viability were as-
essed by using ﬂow cytometry.
Clonogenic assay. Progenitor cell assays were per-
ormed on thawed samples, in duplicate, and only for
nits with a negative sterility test (n  13), by using a
ethyl cellulose–based H4434 medium (Stem Cell
echnologies, Vancouver, BC, Canada). Brieﬂy, 5 104
ells were seeded directly on methyl cellulose, gently
ixed, and then plated on petri dishes and incubated at
7°C in a humidiﬁed atmosphere of 5% CO2 in air.
olony-forming unit–granulocyte-macrophage, burst-orming unit, erythroid, and colony-forming unit–mix
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Predictive Utility of Attached Segment in Quality Control of Cord Blood Graft
Bolonies were identiﬁed and counted according to stan-
ard criteria after 2 weeks in culture [12]. For the CFC
ount, only colonies with more than 50 cells were enu-
erated. The total CFC content, deﬁned as the total
ount of colonies independently of their lineage, was
sed for colony recovery analysis.
Expected clonogenic efﬁciency. Expected clonogenic
fﬁciency (ECLONE) was deﬁned as the ratio between
he CFCs scored in the clonogenic assays and the total
umber of CD34 cells seeded in the same assay [13].
tatistical Analysis
Descriptive analysis is presented as mean  SD.
aired t tests were used to asses differences between
he UCB unit and the related segment. Linear corre-
ation was evaluated and plotted by using Excel 2000
Microsoft Corporation, Redmond, WA), and the co-
fﬁcient of correlation (R2) was calculated.
ESULTS
ord Blood Graft Description
UCB units (volume, 25  1 mL) stored in the
ioarchive system were thawed and assessed for their
ontent. Description of the UCB unit contents, as-
essed by ﬂow cytometry, before cryopreservation and
fter thawing is shown in Table 1. The recovery of
otal CD45 cells and MNCs was 98%  30% and
8%  28%, respectively. Using an automatic cell
ounter, similar recovery of TNCs was observed (94%
9%). However, the recovery obtained for the
D34 cells was lower: 77%  26%.
The viability of CD45 cells, MNCs, and CD34
ells was greater than 90% in fresh samples but
howed reduced values after thawing (Table 1). Com-
ared with other cell types, the CD34 cells showed
igher viability: 80%  14% after thawing.
rogenitor Cell Count on the Attached Segment
redicts UCB Bag Content
In Table 2, descriptive results of total cell contents
able 1. UCB Content before and after Cryopreservation
Variable Fresh After Thawing % Recovery
NC  108 10.4  3.7 10.0  3.8 94  9.0
D45  108 9.30  4.2 8.82  4.8 98  30
NC  108 5.65  2.5 5.34  2.4 98  28
D34/103 TNC 2.03  1.0 1.58  0.7 77  26
iability (7-AAD)
CD45 94  3.3 42  15 —
MNC 90  3.2 63  13 —
CD34 98  2.0 80  14 —
otal cell counts and viabilities are presented as mean  SD.
NC indicates total nucleated cells; MNC, mononucleated cells;
7-AAD, 7-aminoactinomycin D.nd viability obtained after assessment of bags and the †
B & M Torresponding contiguous segments are presented.
here was no signiﬁcant difference between the cells
n the UCB unit and the segment in any of the pa-
ameters assessed. In addition, the linear correlation
f viable CD34 cells was very high between UCB
nits and segments (Figure 1A). The percentage of
iable CD34 cells found within the TNC in the
egment (0.12% 0.1%) was not statistically different
rom that obtained in the bag after thawing (P  .29;
ata not shown).
Finally, the total CFC content after thawing was
.6  105  9.9  105 colonies in the UCB unit and
.1  105  7.0  105 in the segment (P  .29; data
ot shown). Moreover, the CFC content in the unit
nd the attached segment had a high linear correlation
Figure 1B).
omparison of Other Parameters
The cell viability, total CD45 cells, and total
NCs were also compared between UCB units and
he attached segment. In all cases, a strong correlation
as found between samples. Again, for all the param-
ters assessed, differences among bags and segments
ere not statistically signiﬁcant (Table 2). Data from
ucleated cells concentration measured by the auto-
atic cell counter were equivalent between unit and
egment and correlated strongly (P  .29; data not
hown).
se of Colony-Forming Unit/CD34 Correlation as
Qualitative Assessment of Graft Potency
It is interesting to note that the number of CD34
ells and CFCs correlated after thawing both in the
egment and the unit (R2  0.58 and R2  0.77,
espectively; data not shown). In this regard, the num-
er of CFCs expected to be scored according to a
nown number of seeded CD34 cells (ECLONE)
ould be used as a reference value for qualitative as-
able 2. UCB Unit Contents after Thawing and Its Prediction
ssessed by Analysis of the Attached Segment
Variable UCB Unit
Attached
Segment P Value* R2†
NC  108 10.0  3.9 9.53  3.8 .08 0.92
D45  108 8.82  4.8 8.59  4.5 .68 0.74
NC  108 5.34  2.4 5.16  2.0 .53 0.71
D34/103 TNC 1.58  0.7 1.65  0.8 .53 0.85
FC/105 TNC 89.4  61.0 78.9  37.7 .27 0.78
iability (7-AAD)
CD45 42  15 39  15
MNC 63  13 65  19
CD34 80  14 74  16
otal cell counts and viabilities are presented as mean  SD.
NC indicates total nucleated cells; MNC, mononucleated cells;
CFC, colony-forming cells; 7-AAD, 7-aminoactinomycin D.
Associated probability for the 2-tailed Student t-test.
Pearson correlation coeﬁcient.
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2essment of graft potency. We found that the
CLONE for the UCB unit and the related segment
as 51%  31% and 47%  24%, respectively, and
id not show statistical differences between samples (P
.24). Again, the linear correlation was high when
he ECLONE of the samples was plotted (Figure 1C).
ISCUSSION
Selection of a suitable UCB unit for progenitor
ell transplantation is based on HLA matching and the
otal cell content of the unit [14]. Despite a demon-
trated association of TNC [1,15], colony-forming
nit–granulocyte-macrophage [4], and CD34 cell [3]
oses with the speed and probability of neutrophil and
latelet recovery, such variables are currently deter-
ined before cryopreservation, without taking into
ccount that in some cases graft potency might be
ffected by different uncontrolled events during freez-
ng, storing, and shipment of the unit to the transplant
enter. This is particularly relevant in cord blood
anking, where grafts could be stored for years and
here QC before transplantation is usually based only
igure 1. Linear correlation of CD34/103 TNC (A), CFC/105
NC (B), and ECLONE (colony-forming unit/CD34 ratio) (C)
etween the UCB bag and the attached segment.n the TNC count and viability at time of thawing. t
50Although the TNC count measurement is well
tandardized and relatively reproducible between lab-
ratories, it correlates weakly with CD34 content in
ord blood [16]. Consequently, one might ﬁnd a se-
ected unit with an acceptable TNC count after thaw-
ng that contains a very low number of CD34 cells
nd CFCs [8] and that, therefore, has a reduced prob-
bility of engraftment. This situation has already been
eported [7], and it is not possible to know how often
n appropriate QC before transplantation could have
revented other engraftment failures. Moreover, the
lection of a UCB unit for transplantation has some
egree of uncertainty due to the different protocols,
ack of standardized techniques, cord blood banks, and
ransplant centers involved in this process. Recently,
an haute et al. [16] published a study in which the
est predictor of viable CD34 cells obtained in the
ransplantation bag was obtained from a reference
ample assessment.
In this study, we focused on demonstrating that
he analysis of a contiguous segment may be used to
redict the content and graft potential of the trans-
lantation unit by using the variables described here.
aken together, our results suggest that, for all the
ariables assessed (TNC, MNC, CD45, CD34, and
FC), the number of cells and viability in the attached
egment with this particular freezing bag (Thermo-
enesis) and with the freezing protocol described will
e representative of the graft. Whether this result can
e extended to freezing bags with different geometry
nd to other freezing methods remains to be deter-
ined.
It is interesting to note that the CFC/CD34 ratio
etermined in the UCB bag was conserved in the
ttached segment. As a result, the percentage of col-
nies generated per CD34 cell seeded is expected to
e constant in a speciﬁc unit after thawing
ECLONE). By assessing the speciﬁc ECLONE of a
rogenitor source, we could deﬁne normality ranges
or the qualitative detection of functional defects after
ryopreservation by using the colony score. This ﬁnd-
ng is suported by the fact that the CFC/CD34 ratio
as been already reported as a good predictor in short-
erm platelet engraftment in mobilized blood progen-
tor cell transplantation [13]. In this respect, and es-
ecially for practical application of this parameter,
FC assays and cytometry techniques in thawed sam-
les should be carefully standardized. In our experi-
nce, special attenttion should be taken to avoid os-
otic shock in thawed samples. Direct dilution in lysis
uffers, as with those used in cytometry, might inﬂu-
nce the absolute counts, as well as the viability, of the
ells. In this study, a possible underestimation of the
umber of CD34 cells might have inﬂuenced the
nnexpectedly low recovery values observed. In addi-
ion, the high ECLONE values observed could reﬂect
his situation, because the aliquots taken for CFC
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Predictive Utility of Attached Segment in Quality Control of Cord Blood Graft
Bssesment were directly diluted in the methyl cellulose
edium, thus avoiding the osmotic shock produced by
he lysis reagent used in ﬂow cytometry.
The use of the segment to predict the hematopoi-
tic potential of the graft requires that the cord blood
ank standardize and validate a reproducible method
o generate and analyze these samples. Additionally,
uch analyses could be useful in determining the real
otential of all the events that occur during storage.
inally, at the transplant center, the attached segment
ay serve as a means to assess the progenitor cell
ontent of the unit according to its own analysis tech-
iques and stringencies without compromising the
ord blood graft.
In conclusion, using well-controlled and standard-
zed conditions, we can use the segment physically
inked to the transplantation bag to predict the cell
nd progenitor cell content of a cord blood graft. The
se of a segmental minithaw technique performed in
he cord blood bank or after shipment to the trans-
lant center facility could minimize the risk of graft
ailure secondary to undetected loss of functional ac-
ivity of the cord blood product before transplanta-
ion.
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